This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

ResMed Inc (RMD)

NYSE: Health Care

Company Cash Flow
Jun 2015 Jun 2014 Jun 2013 Jun 2012
Cash Flow From Operating Activities
Net Income (Loss) 352.89M 345.27M 307.13M 0.00
Operating Gains/Losses -709.00K 0.00 0.00 -15.72M
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables -28.26M -35.11M -37.27M -20.29M
(Increase) Decrease in Inventories -99.52M -15.85M 27.14M 18.81M
(Increase) Decrease In Other Current Assets 0.00 0.00 0.00 0.00
(Decrease) Increase In Payables 85.81M 3.10M 29.63M 72.80M
(Decrease) Increase In Other Current Liabilities 0.00 0.00 0.00 0.00
(Increase) Decrease In Other Working Capital 0.00 0.00 0.00 0.00
Other Non-Cash Items 22.76M 14.59M 26.58M 279.65M
Net Cash From Continuing Operations 383.18M 391.27M 402.82M 383.16M
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 383.18M 391.27M 402.82M 383.16M
Sale of Property, Plant & Equipment 0.00 0.00 0.00 0.00
Cash Used for Investing Activities
Sale of Short-Term Investments 0.00 0.00 0.00 18.57M
Purchases of Property, Plant & Equipment -71.94M -81.16M -71.78M -61.11M
Acquisitions -29.41M -3.85M -5.42M -53.32M
Purchases of Short-Term Investments 0.00 0.00 0.00 0.00
Other Cash from Investing Activities -31.91M 871.00K 1.43M -1.46M
Cash Provided by Financing Activities
Net Cash From Investing Activities -143.07M -94.99M -78.00M -101.61M
Issuance of Debt 180.00M 0.00 150.00M 0.00
Cash Used for Financing Activities
Issuance of Capital Stock 38.81M 33.35M 69.24M 62.49M
Repayment of Long-Term Debt -181.54M -560.03M -100.22M -125.98M
Repurchase of Capital Stock -160.30M -202.17M -186.26M -392.74M
Payment of Cash Dividends -157.26M -141.52M -97.20M 0.00
Other Financing Charges, Net 24.50M 573.05M 10.52M 279.13M
Net Cash From Financing Activities -255.79M -297.32M -153.93M -177.10M
Effect of Exchange Rate Changes -172.80M 30.72M -104.39M -30.16M
Net Change in Cash & Cash Equivalents -188.48M 29.68M 66.51M 74.27M
RMD News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

Analysts Ratings for RMD

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 3 3 3 3
Moderate Buy 2 2 2 2
Hold 4 4 4 4
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 1

RMD Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs